In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

Table 1

Distribution of each pathogen based on the drug-resistant patterns and sources ().

Source	Non-MDR	MDR	XDR	PDR
	(%)	(%)	(%)	(%)
A. baumannii
Sputum ()	1 (50.0)	6 (66.7)	7 (63.6)	1 (50.0)
Tissue ()	—	1 (11.1)	2 (18.2)	—
Blood ()	—	1 (11.1)	1 (9.1)	—
BAL ()	1 (50.0)	—	—	1 (50.0)
Urine ()	—	—	1 (9.1)	—
Stool ()	—	1 (11.1)	—	—
P. aeruginosa
Sputum ()	—	5 (55.6)	2 (20.0)	—
Tissue ()	—	—	1 (10.0)	1 (100)
BAL ()	—	—	1 (10.0)	—
Urine ()	—	1 (11.1)	—	—
Wound ()	—	—	3 (30.0)	—
Pus ()	—	—	1 (10.0)	—
Others ()	—	3 (33.3)	2 (20.0)	—
K. pneumoniae
Sputum ()	2 (66.7)	2 (33.3)	3 (23.1)	1 (50.0)
Tissue ()	—	—	1 (7.7)	—
Blood ()	—	—	1 (7.7)	—
BAL ()	—	1 (16.7)	1 (7.7)	—
Urine ()	1 (33.3)	—	1 (7.7)	—
Stool ()	—	2 (33.3)	—	—
Wound ()	—	—	1 (7.7)	1 (50.0)
Pus ()	—	—	2 (15.4)	—
Others ()	—	1 (16.7)	3 (23.1)	—

BAL: bronchoalveolar lavage.